Clinical Trial Detail

NCT ID NCT03035331
Title Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mayo Clinic
Indications

non-Hodgkin lymphoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.